The Ichthyoses pp 223-231 | Cite as

Topical Therapy

  • Heiko Traupe


Topical treatment modalities are still the backbone of successful therapy in the various cornification disorders. Because of a certain disillusionment regarding the safety of systemic long-term therapy with retinoids, topical preparations have regained much of their former importance. One should not forget, however, that many of the topical treatment modalities now in everyday use have never undergone a thorough and critical evaluation process, but have been handed down by previous generations of dermatologists or dermatology schools. The assertion that, for instance, long-term treatment with salicylic acid is safe lacks a scientific basis.


Salicylic Acid Stratum Corneum Topical Therapy Netherton Syndrome Lamellar Ichthyosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Baden HP, Alper JL (1973) A keratolytic gel containing salicylic acid in propylene glycol. J Invest Dermatol 61:330–333PubMedCrossRefGoogle Scholar
  2. 2.
    Beverley DW, Wheeler D (1986) High plasma urea concentrations in collodion babies. Arch Dis Child 61:696–698PubMedCrossRefGoogle Scholar
  3. 3.
    Buxman M, Hickman J, Ragsdale W, Stretcher G, Krochmal L, Wehr RF (1986) Therapeutic activity of lactate 12% lotion in the treatment of ichthyosis. Active versus vehicle and active versus a petrolatum cream. J Am Acad Dermatol 15:1253–1258PubMedCrossRefGoogle Scholar
  4. 4.
    Friedman SH (1987) Lindane neurotoxic reaction in nonbullous congenital ichthyosiform erythroderma. Arch Dermatol 123:1056–1058PubMedCrossRefGoogle Scholar
  5. 5.
    Garty BZ (1986) High plasma urea concentration in babies with lamellar ichthyosis. Arch Dis Child 61:1245–1246PubMedCrossRefGoogle Scholar
  6. 6.
    Garty BZ, Wiseman Y, Metzker A, Reisner SH, Nitzan M (1985) Hypernatremic dehydration and hypothermia in congenital lamellar ichthyosis. Pediatr Dermatol 3:65–68PubMedCrossRefGoogle Scholar
  7. 7.
    Goldsmith LA (1978) Propylene glycol. Int J Dermatol 17:703–705PubMedGoogle Scholar
  8. 8.
    Goldsmith LA, Baden HP (1972) Management and treatment of ichthyosis. N Engl J Med 286:821–823PubMedCrossRefGoogle Scholar
  9. 9.
    Ibsen HH, Brandrup F (1984) Topical cholesterol treatment of recessive X-linked ichthyosis. Lancet 2:645PubMedCrossRefGoogle Scholar
  10. 10.
    Korting GW (1974) Therapie der Hautkrankheiten. Ein Lehrbuch für die Praxis, 3rd edn. Schattauer, Stuttgart, pp 111–116Google Scholar
  11. 11.
    Lawlor F, Peiris S (1985) Harlequin fetus successfully treated with etretinate. Br J Dermatol 112:585–590PubMedCrossRefGoogle Scholar
  12. 12.
    Lykkesfeldt G, Hoyer H (1983) Topical cholesterol treatment of recessive X-linked ichthyosis. Lancet 2:1337–1338PubMedCrossRefGoogle Scholar
  13. 13.
    Maloney ME, Williams ML, Epstein EH, Law MYL, Fritsch PO, Elias PM (1984) Lipids in the pathogenesis of ichthyosis: topical cholesterol sulfate-induced scaling in hairless mice. J Invest Dermatol 83:252–256PubMedCrossRefGoogle Scholar
  14. 14.
    Maibach H, Boisits E (eds) (1982) Neonatal skin structure and function. Dekker, New YorkGoogle Scholar
  15. 15.
    Müller KH, Pflugshaupt C (1979) Harnstoff in der Dermatologie. Literaturübersicht. Zentralbl Haut-Geschlechtskr 142:157–168Google Scholar
  16. 16.
    Rasmussen JE (1979) Percutaneous absorption in children. In: Dobson RL (ed) Year book of dermatology 1979. Year Book Medical, Chicago, pp 15–38Google Scholar
  17. 17.
    Schrader K, Bielfeldt S (1988) Die Beeinflussung der Hautfeuchtigkeit und Hautglätte durch den “Biokatalysator” Adenosintriphosphat (ATP). Ärztl Kosmet 18:372–378Google Scholar
  18. 18.
    Siemens HW (1928) Zur Differentialdiagnose und Prognose der überlebenden Fälle von Ichthyosis congenita. Arch Dermatol Syph (Berl) 156:624–655CrossRefGoogle Scholar
  19. 19.
    Stüttgen G (1962) Zur Lokalbehandlung von Keratosen mit Vitamin-A-Säure. Dermatologica 124:65–80CrossRefGoogle Scholar
  20. 20.
    Stüttgen G (1987) Eczema therapy and permeability of infantile skin for topical preparations. In: Happle R, Grosshans E (eds) Pediatric dermatology. Advances in diagnosis and treatment. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  21. 21.
    Swanbeck G (1968) A new treatment of ichthyosis and other hyperkeratotic conditions. Acta Derm Venereol (Stockh) 48:123–127Google Scholar
  22. 22.
    Swanbeck G (1978) The effect of urea on the skin with special reference to the treatment of ichthyosis. In: Marks R, Dykes PJ (eds) The ichthyoses. MTP, Lancaster, pp 163–166CrossRefGoogle Scholar
  23. 23.
    Taylor JR, Halprin K (1975) Percutaneous absorption of salicylic acid. Arch Dermatol 106:740–743CrossRefGoogle Scholar
  24. 24.
    Van Scott EJ, Yu RJ (1974) Control of keratinization with a-hydroxy acids and related compounds. I. Topical treatment of ichthyotic disorders. Arch Dermatol 110:586–590PubMedCrossRefGoogle Scholar
  25. 25.
    Van Scott EJ, Yu RJ (1984) Hyperkeratinization, comeocyte cohesion, and alpha-hydroxy acids. J Am Acad Dermatol 11:867–879PubMedCrossRefGoogle Scholar
  26. 26.
    Van Weiss DF, Lever WF (1964) Percutaneous salicylic acid intoxication in psoriasis. Arch Dermatol 90:614–619CrossRefGoogle Scholar
  27. 27.
    Wester RC, Noonan PK, Cole MP, Maibach HI (1977) Percutaneous absorption of testosterone in the newborn rhesus monkey. Comparison to the adult. Pediatr Res 11:737–739PubMedCrossRefGoogle Scholar
  28. 28.
    Würsch TG (1980) Topische Behandlung von vulgären Ichthyosen mit Carbamid und Vitamin-A-Säure-haltigen Externa. Schweiz Rundsch Med Prax 69:1060–1063Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • Heiko Traupe
    • 1
  1. 1.Department of Human GeneticsUniversity of NijmegenHB NijmegenThe Netherlands

Personalised recommendations